Recent advances in both cardiac tissue engineering and hearts‐on‐a‐chip are grounded in
new biomaterial development as well as the employment of innovative fabrication …

Myocardial infarction (MI), which causes irreversible myocardium necrosis, affects 0.25
billion people globally and has become one of the most significant epidemics of our time …

Abstract 3D‐bioprinting is a promising technology to produce human tissues as drug
screening tool or for organ repair. However, direct printing of living cells has proven difficult …

It remains a significant challenge to fabricate natural polymer (NP) hydrogels with anti-
swelling ability and high strengths in the physiological environment. Herein, the β-sheet …

The survival and function of tissues depend on appropriate vascularization. Blood vessels of
the tissues supply oxygen, and nutrients and remove waste and byproducts. Incorporating …

The fabrication of scaffolds capable of the sustained release of the vascular endothelial
growth factor (VEGF) to promote angiogenesis for a long time remains a challenge in tissue …

Cardiac tissue engineering has been rapidly evolving with diverse applications, ranging
from the repair of fibrotic tissue caused by “adverse remodeling,” to the replacement of …

In recent years, 3D bioprinting with various types of bioinks has been widely used in tissue
engineering to fabricate human tissues and organs with appropriate biological functions …

Cardiovascular disease has emerged as the leading cause of death worldwide. Since
coronary arteries, carotid arteries, and other blood vessels are prone to narrowing, small …

Abstract Three-dimensional (3D) printing has attracted increasing research interest as an
emerging manufacturing technology for developing sophisticated and exquisite architecture …